Chemoinformaics analysis of 2,6-Dimethyloct-7-ene-2,3,6-triol
Molecular Weight | 188.267 | nRot | 5 |
Heavy Atom Molecular Weight | 168.107 | nRig | 1 |
Exact Molecular Weight | 188.141 | nRing | 0 |
Solubility: LogS | -0.617 | nHRing | 0 |
Solubility: LogP | 0.43 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 32.4419 |
nHD | 3 | BPOL | 20.0641 |
QED | 0.56 |
Synth | 3.846 |
Natural Product Likeliness | 2.607 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.008 |
HIA | 0.019 |
CACO-2 | -4.314 |
MDCK | 0.0000178 |
BBB | 0.95 |
PPB | 0.297416 |
VDSS | 0.699 |
FU | 0.575159 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.211 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.751 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.587 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.126 |
CYP3a4-inh | 0.032 |
CYP3a4-sub | 0.232 |
CL | 4.844 |
T12 | 0.66 |
hERG | 0.017 |
Ames | 0.017 |
ROA | 0.047 |
SkinSen | 0.087 |
Carcinogencity | 0.02 |
EI | 0.896 |
Respiratory | 0.027 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.841822 |